Home › Funds › Jones Hill Capital LP › NUVB
Jones Hill Capital LP position in NUVB
NUVATION BIO INC · Health Care
Jones Hill Capital LP reported holding 4,486,986 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$25.1M, representing 4.26% of its reported portfolio and ranking #9 among its reported holdings. Jones Hill Capital LP has disclosed NUVB holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's NUVB position evolved
Jones Hill Capital LP first disclosed a stake in NUVB in Q1 2026 at 2,383,031 shares (US$10.2M). The position peaked in Q3 2026 at 4,486,986 shares, worth US$25.1M. Across 2 filings, Jones Hill Capital LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 4,486,986 shares valued at US$25.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.38M | $10.22M | New |
| Q3 2026 | 4.49M | $25.13M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Context Capital Management, LLC (US$53.1M), Omega Fund Management, LLC (US$45.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Context Capital Management, LLC 52.00M sh · $53.13M · Q3 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.70M sh · $43.10M · Q3 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held NUVB?
Jones Hill Capital LP has disclosed NUVB holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Jones Hill Capital LP's current position in NUVB?
As of Q3 2026, Jones Hill Capital LP holds 4.49M shares of NUVB (NUVATION BIO INC), valued at $25.13M, representing 4.26% of its reported portfolio and ranking #9.
Has Jones Hill Capital LP been buying or selling NUVB?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP newly opened its position in NUVB. The position peaked in Q3 2026 at 4.49M shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Omega Fund Management, LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.